(S)-HDAC-IN-102

Overview

(S)-HDAC-IN-102 is a HDAC8 inhibitor and an isomer of HDAC-IN-102 ( HY-185554 ). HDAC-IN-102 inhibits total HDAC with an IC 50 of 58 μM and exhibits partial subtype selectivity. Specifically, (S)-HDAC-IN-102 targets HDAC8 , while (R)-HDAC-IN-102 ( HY-185554B ) targets HDAC2 . HDAC-IN-102 exerts antioxidant effects by scavenging DPPH free radicals and can be used in cancer-related research.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > Free Radical Scavengers | Products > Signaling Pathways > HDAC

Product Information

• Catalog No.: HY-185554A
• CAS No.: 748159-43-5
• Molecular Formula: C18H28O4
• Molecular Weight: 308.41
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source